Journal
NUTRIENTS
Volume 9, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/nu9101046
Keywords
resveratrol; antiproliferation; cancer; tetrac; Nano-diamino-tetrac
Categories
Funding
- TMU
- National Taipei University of Technology [USTP-NTUT-TMU-104-09]
- Ministry of Education (TMU Top University Fund)
- Ministry of Science and Technology, Taiwan [MOST 104-2314-B-038-046-MY3, MOST105-2320-B-038-006]
Ask authors/readers for more resources
Preclinical and clinical studies have offered evidence for protective effects of various polyphenol-rich foods against cardiovascular diseases, neurodegenerative diseases, and cancers. Resveratrol is among the most widely studied polyphenols. However, the preventive and treatment effectiveness of resveratrol in cancer remain controversial because of certain limitations in existing studies. For example, studies of the activity of resveratrol against cancer cell lines in vitro have often been conducted at concentrations in the low mu M to mM range, whereas dietary resveratrol or resveratrol-containing wine rarely achieve nM concentrations in the clinic. While the mechanisms underlying the failure of resveratrol to inhibit cancer growth in the intact organism are not fully understood, the interference by thyroid hormones with the anticancer activity of resveratrol have been well documented in both in vitro and xenograft studies. Thus, endogenous thyroid hormones may explain the failure of anticancer actions of resveratrol in intact animals, or in the clinic. In this review, mechanisms involved in resveratrol-induced antiproliferation and effects of thyroid hormones on these mechanisms are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available